Clinical Trials Browser

Has results × Hematologic Neoplasms × Everolimus × Clear all

NCT00935792 2017-09-26

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1/2 Completed

28 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Lymphoid, Hematologic Neoplasms

NCT00790036 2017-07-12

PILLAR2

Phase 3 Completed

742 enrolled 10 charts

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms